Sun Pharmaceutical Industries Limited announced earnings results for the fourth quarter ended March 31, 2021. For the fourth quarter, the company announced total revenue was INR 86,339.8 million compared to INR 82,871.7 million a year ago. Net income was INR 8,941.5 million compared to INR 3,998.4 million a year ago. Basic earnings per share from continuing operations was INR 3.7 compared to INR 1.7 a year ago. For the full year, total revenue was INR 343,336.6 million compared to INR 334,734.8 million a year ago. Net income was INR 29,038.2 million compared to INR 37,649.3 million a year ago. Basic earnings per share from continuing operations was INR 12.1 compared to INR 15.7 a year ago.